← All drugs
Drug

Carmustine

185 flagged reaction(s) · 7,936 total co-reports · max PRR 94.9
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Myelodysplastic Syndrome 296 94.9 101.4 signal
2 Acute Myeloid Leukaemia 172 50.8 52.7 signal
3 Brain Oedema 137 49.9 51.4 signal
4 Mucosal Inflammation 219 38.5 40.4 signal
5 Haematotoxicity 65 32.1 32.5 signal
6 Febrile Neutropenia 391 27.0 29.4 signal
7 Pneumocystis Jirovecii Pneumonia 50 22.9 23.1 signal
8 Therapy Partial Responder 69 20.9 21.2 signal
9 Cytomegalovirus Infection 74 20.3 20.6 signal
10 Cytopenia 50 19.1 19.3 signal
11 Acute Respiratory Distress Syndrome 63 16.2 16.5 signal
12 Bacteraemia 40 15.5 15.6 signal
13 Basal Cell Carcinoma 50 14.6 14.7 signal
14 Cytokine Release Syndrome 60 14.4 14.5 signal
15 Lymphoma 47 13.8 14.0 signal
16 Clostridium Difficile Colitis 28 12.0 12.1 signal
17 Lymphopenia 37 12.0 12.1 signal
18 Disease Progression 292 11.3 12.0 signal
19 Nephropathy Toxic 27 11.0 11.1 signal
20 Septic Shock 101 10.6 10.9 signal
21 Thrombocytopenia 250 10.2 10.7 signal
22 Status Epilepticus 23 9.3 9.3 signal
23 Post Procedural Complication 39 9.2 9.3 signal
24 Blood Lactate Dehydrogenase Increased 32 9.1 9.2 signal
25 Bone Marrow Failure 41 9.1 9.2 signal
26 Staphylococcal Infection 66 9.1 9.2 signal
27 Intestinal Perforation 22 8.9 9.0 signal
28 Candida Infection 32 8.7 8.8 signal
29 Pancytopenia 105 8.6 8.8 signal
30 Ataxia 22 8.4 8.4 signal
31 Wound Infection 20 8.4 8.4 signal
32 Colitis 69 8.3 8.5 signal
33 Multi-organ Failure 32 8.3 8.4 signal
34 Glomerular Filtration Rate Decreased 22 8.3 8.3 signal
35 Device Related Infection 28 8.3 8.3 signal
36 Drug Toxicity 25 8.2 8.3 signal
37 Pneumonitis 48 8.1 8.2 signal
38 Hepatotoxicity 39 8.0 8.1 signal
39 Leukopenia 84 7.7 7.8 signal
40 Posterior Reversible Encephalopathy Syndrome 16 7.7 7.7 signal
41 Multiple Organ Dysfunction Syndrome 46 7.5 7.6 signal
42 Myelosuppression 56 7.5 7.6 signal
43 Lymphadenopathy 58 7.5 7.5 signal
44 Hepatocellular Injury 23 7.4 7.4 signal
45 Neurotoxicity 27 7.1 7.1 signal
46 Neutropenia 206 6.9 7.2 signal
47 Hemiparesis 25 6.7 6.7 signal
48 Cholestasis 28 6.7 6.7 signal
49 Bacterial Infection 27 6.6 6.7 signal
50 Thrombotic Microangiopathy 14 6.6 6.6 signal
51 Sepsis 159 6.5 6.7 signal
52 Cerebral Infarction 34 6.3 6.4 signal
53 Ileus 17 6.3 6.3 signal
54 Subarachnoid Haemorrhage 14 6.2 6.3 signal
55 Neoplasm Progression 48 6.2 6.3 signal
56 Disease Recurrence 65 6.2 6.3 signal
57 Agranulocytosis 24 5.9 5.9 signal
58 Malignant Neoplasm Progression 129 5.8 5.9 signal
59 Infection 177 5.6 5.8 signal
60 Stomatitis 73 5.5 5.5 signal
61 Respiratory Failure 86 5.4 5.4 signal
62 Atelectasis 11 5.2 5.2 signal
63 Metastases To Lung 13 5.1 5.1 signal
64 Polyneuropathy 13 5.0 5.0 signal
65 Convulsion 63 4.9 5.0 signal
66 Clostridium Difficile Infection 23 4.8 4.8 signal
67 Subdural Haematoma 15 4.8 4.8 signal
68 Aphasia 31 4.7 4.7 signal
69 Tubulointerstitial Nephritis 19 4.6 4.6 signal
70 Pneumothorax 16 4.6 4.6 signal
71 Respiratory Tract Infection 26 4.6 4.6 signal
72 Haemorrhage Intracranial 15 4.5 4.6 signal
73 Blood Bilirubin Increased 27 4.5 4.6 signal
74 Acute Respiratory Failure 19 4.5 4.5 signal
75 Toxic Skin Eruption 10 4.5 4.5 signal
76 End Stage Renal Disease 18 4.4 4.5 signal
77 Hyperbilirubinaemia 10 4.4 4.4 signal
78 Appendicitis 9 4.4 4.4 signal
79 Fungal Infection 31 4.2 4.3 signal
80 Drug Eruption 16 4.1 4.1 signal
81 Paralysis 13 4.1 4.1 signal
82 Gastric Cancer 23 4.1 4.1 signal
83 Neutrophil Count Decreased 36 4.0 4.1 signal
84 Cardiomyopathy 13 4.0 4.0 signal
85 Osteonecrosis 29 4.0 4.0 signal
86 Encephalopathy 21 3.9 3.9 signal
87 Pulmonary Embolism 81 3.9 3.9 signal
88 Alanine Aminotransferase Increased 52 3.9 3.9 signal
89 Viral Infection 28 3.8 3.8 signal
90 Covid-19 Pneumonia 10 3.8 3.8 signal
91 Autoimmune Disorder 8 3.8 3.8 signal
92 Nervous System Disorder 26 3.8 3.8 signal
93 Hepatitis 21 3.7 3.7 signal
94 Neuropathy Peripheral 76 3.7 3.7 signal
95 Lymphocyte Count Decreased 14 3.6 3.6 signal
96 Renal Failure Acute 34 3.6 3.6 signal
97 Coagulopathy 13 3.6 3.6 signal
98 Deep Vein Thrombosis 51 3.6 3.6 signal
99 Ejection Fraction Decreased 12 3.5 3.5 signal
100 Immune System Disorder 10 3.5 3.5 signal
101 Scar 13 3.4 3.5 signal
102 Mental Status Changes 21 3.4 3.4 signal
103 Intentional Product Use Issue 66 3.4 3.4 signal
104 Drug Resistance 19 3.4 3.4 signal
105 Deafness 19 3.3 3.3 signal
106 Pyrexia 239 3.1 3.3 signal
107 Drug Level Decreased 7 3.1 3.1 signal
108 Metastases To Liver 12 3.1 3.1 signal
109 Pulmonary Fibrosis 13 3.1 3.1 signal
110 Sudden Death 7 3.0 3.0 signal
111 Pericardial Effusion 15 3.0 3.0 signal
112 Dermatitis Allergic 8 2.9 2.9 signal
113 Oesophagitis 7 2.9 2.9 signal
114 Product Use In Unapproved Indication 155 2.9 3.0 signal
115 Pneumonia 202 2.8 2.9 signal
116 Platelet Count Decreased 65 2.8 2.8 signal
117 Renal Tubular Necrosis 6 2.8 2.8 signal
118 Anaemia 116 2.8 2.8 signal
119 Atrial Fibrillation 58 2.7 2.7 signal
120 Off Label Use 515 2.7 2.9 signal
121 Emphysema 6 2.7 2.7 signal
122 Lung Disorder 29 2.7 2.7 signal
123 Herpes Zoster 34 2.7 2.7 signal
124 Eyelid Ptosis 6 2.7 2.7 signal
125 Inappropriate Antidiuretic Hormone Secretion 6 2.7 2.7 signal
126 Cerebral Haemorrhage 21 2.7 2.7 signal
127 Petechiae 6 2.6 2.6 signal
128 Pleural Effusion 35 2.6 2.6 signal
129 Jaundice 15 2.5 2.5 signal
130 Impaired Healing 18 2.5 2.5 signal
131 Rash Maculo-papular 12 2.5 2.5 signal
132 Squamous Cell Carcinoma 5 2.4 2.4 no signal
133 Hepatic Failure 16 2.4 2.4 signal
134 Renal Impairment 44 2.4 2.4 signal
135 Coma 25 2.4 2.4 signal
136 Pulmonary Oedema 23 2.3 2.3 signal
137 Altered State Of Consciousness 11 2.3 2.3 signal
138 Ill-defined Disorder 31 2.3 2.3 signal
139 Respiratory Disorder 15 2.3 2.3 signal
140 Interstitial Lung Disease 24 2.3 2.3 signal
141 Thyroid Cancer 6 2.3 2.3 no signal
142 Epilepsy 15 2.2 2.2 signal
143 Hepatic Cytolysis 6 2.2 2.2 no signal
144 Drug Ineffective For Unapproved Indication 27 2.2 2.2 signal
145 Immunodeficiency 7 2.2 2.2 no signal
146 Fluid Overload 7 2.2 2.2 no signal
147 Cardiac Failure 38 2.2 2.2 signal
148 Hypothyroidism 15 2.1 2.1 signal
149 Lung Infection 7 2.0 2.0 no signal
150 Brain Neoplasm 4 2.0 2.0 no signal
151 Neoplasm 5 2.0 2.0 no signal
152 Gastric Haemorrhage 5 2.0 2.0 no signal
153 Splenomegaly 5 1.9 1.9 no signal
154 Disseminated Intravascular Coagulation 6 1.9 1.9 no signal
155 Hepatitis C 5 1.9 1.9 no signal
156 No Therapeutic Response 5 1.8 1.8 no signal
157 Cyst 5 1.8 1.8 no signal
158 Tooth Extraction 5 1.8 1.8 no signal
159 Intestinal Obstruction 15 1.8 1.8 no signal
160 Drug Reaction With Eosinophilia And Systemic Symptoms 10 1.8 1.8 no signal
161 Mydriasis 5 1.8 1.8 no signal
162 Tuberculosis 5 1.8 1.8 no signal
163 Folliculitis 4 1.8 1.8 no signal
164 Palmar-plantar Erythrodysaesthesia Syndrome 9 1.7 1.8 no signal
165 Toxicity To Various Agents 64 1.7 1.7 no signal
166 Proteinuria 7 1.7 1.7 no signal
167 Pulmonary Arterial Hypertension 5 1.6 1.6 no signal
168 Ischaemic Stroke 6 1.5 1.5 no signal
169 Plasma Cell Myeloma 13 1.5 1.5 no signal
170 Femur Fracture 10 1.5 1.5 no signal
171 Diarrhoea Haemorrhagic 3 1.5 1.5 no signal
172 Leukaemia 3 1.4 1.4 no signal
173 Metastases To Central Nervous System 4 1.4 1.4 no signal
174 Anorexia 4 1.4 1.4 no signal
175 Amenorrhoea 5 1.4 1.4 no signal
176 Malignant Melanoma 4 1.4 1.4 no signal
177 Multiple Sclerosis 14 1.3 1.3 no signal
178 Peritonitis 6 1.3 1.3 no signal
179 Central Nervous System Lesion 4 1.3 1.3 no signal
180 Fistula 3 1.2 1.2 no signal
181 Drug Administration Error 8 1.2 1.2 no signal
182 Drug Effective For Unapproved Indication 7 1.1 1.1 no signal
183 Breast Cancer 13 0.6 0.6 no signal
184 Prostate Cancer 9 0.5 0.5 no signal
185 Bladder Cancer 3 0.2 0.2 no signal